Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net income $ 343,629 $ 241,638
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,616 7,369
Valuation adjustment of mortgage servicing rights (247,439) 84,581
Valuation adjustment of mortgage loans held for sale 65,297 59,040
Unrealized (gain) loss on derivatives (22,366) 52,758
Amortization of right-of-use assets 12,408 11,619
Provision for investor reserves 679 7,581
Reversal of provision for foreclosure losses (1,974) (306)
Valuation adjustment of contingent liabilities due to acquisitions (45,075) 18,587
Gain on sale of mortgage loans excluding fair value of other financial instruments, net (440,974) (1,019,439)
Deferred income taxes 98,373 11,222
Other (8,277) 2,533
Benefit from investor reserves (3,101) (4,958)
Foreclosure loss reserve (1,436) (1,427)
Stock-based compensation 4,917 4,596
Changes in operating assets and liabilities:    
Origination of mortgage loans held for sale (16,265,741) (28,192,471)
Proceeds on sale of and payments from mortgage loans held for sale 17,916,073 29,847,321
Accounts and interest receivable 39,674 (5,955)
Other assets (2,945) (7,901)
Mortgage servicing rights (206,772) (257,917)
Accounts payable and accrued expenses (15,932) (1,620)
Accrued compensation and benefits (39,622) (36,938)
Income taxes 4,938 (24,595)
Contingent liability payments (7,125) (23,448)
Operating lease liabilities (12,075) (8,766)
Deferred compensation plan liability 4,530 6,038
Real estate owned, net (199) 171
Net cash provided by operating activities 1,181,081 769,313
Cash flows from investing activities    
Acquisition of business, net of cash acquired 0 (86,864)
Proceeds from the sale of property and equipment 177 115
Purchases of property and equipment (3,158) (3,538)
Net cash used in investing activities (2,981) (90,287)
Cash flows from financing activities    
Borrowings on warehouse lines of credit 16,006,430 27,415,569
Repayments on warehouse lines of credit (17,113,148) (28,082,761)
Borrowings on MSR notes payable 0 23,500
Repayments on MSR notes payable (137,500) (4,250)
Contingent liability payments (7,300) 0
Net change in notes payable (1,784) (1,764)
Repurchases of Class A common stock (2,968) 0
Dividends paid 0 (60,000)
Net cash used in financing activities (1,256,270) (709,706)
Decrease in cash, cash equivalents and restricted cash (78,170) (30,680)
Cash, cash equivalents and restricted cash, beginning of period 248,120 339,633
Cash, cash equivalents and restricted cash, end of period 169,950 308,953
Cash, cash equivalents and restricted cash at end of period are comprised of the following:    
Cash and cash equivalents 162,198 302,931
Restricted cash 7,752 6,022
Total cash, cash equivalents and restricted cash 169,950 308,953
Supplemental information    
Cash paid for interest, net 26,291 33,947
Cash paid for income taxes, net of refunds (3,745) 96,717
Supplemental disclosure of non-cash investing activities:    
Measurement period adjustment to goodwill $ (1,710) $ 0